<p>(<b>A</b>) Equal amounts of recombinant rhFLSC protein, HIV<sub>BaL</sub>gp120 protein, or lysate from CV-1 cells collected 48 hpi were separated by SDS-PAGE, transferred to nitrocellulose, and exposed to pooled sera from mice vaccinated with the indicated viruses. The washed blots were then exposed to HRP conjugated anti-mouse IgG. (<b>B</b>) Similarly, blots of HIV<sub>BaL</sub>gp120 protein and lysate from CV-1 cells collected 48 hpi were incubated with pooled mouse sera and then with HRP conjugated anti-mouse IgG1 or to HRP conjugated anti-mouse IgG2a as indicated. Figures shown are representative of 2–5 experiments.</p
<p>ELISA plates were coated with 2 μg/ml VLPs, gp120 Env, or Pr55 Gag. IgG1 quantitative ELISA of po...
<p>(A) 2x10<sup>10</sup> vp/mL of Ad5, Ad26 or Ad26 hexon modified vectors were incubated with RPMI-...
<p>The anti-HIV-1 antibody production in mouse sera is shown at days 0 (T0), 14 (T1 and 28 (T2) from...
<p>Sera collected from immunized mice were diluted and used in ELISA assays to examine IgG1 and IgG2...
<p>BALB/c mice were immunized once with DNA encoding the indicated vaccine constructs. DNA (25 µg DN...
<p>Serum was collected from individual mouse immunized with DNA-B/MVA-B, DNA-B/MVA-B ΔC6L or DNA-B/M...
<p> Serum from individual immunized mice was analyzed using an HIV-1<sub>JR-CSF</sub> gp160 ELISA as...
<p>(A–B) Specific binding antibodies in immunized mouse sera to Bal gp120 (A) and HIV-1 06044 gp120 ...
<p>ELISA wells were coated with gp120<sub>MN</sub> or with MCPs listed in the Table, and antibody ti...
A) Schematic of the HIV Env or EboGP-pseudotyped HIV VLP immunization protocol used in this study. T...
In the present work we report our preliminary data demonstrating the susceptibility of mouse to HIV ...
In the present work we report our preliminary data demonstrating the susceptibility of mouse to HIV ...
<p><b>(A)</b> Serum of immunized mice from the memory phase were analyzed for total IgG response usi...
The immune parameters of HIV/AIDS vaccine candidates that might be relevant in protection against HI...
<p>Per antigen, eight mice were vaccinated twice with 5 µg antigen mixed with an oil-in-water adjuva...
<p>ELISA plates were coated with 2 μg/ml VLPs, gp120 Env, or Pr55 Gag. IgG1 quantitative ELISA of po...
<p>(A) 2x10<sup>10</sup> vp/mL of Ad5, Ad26 or Ad26 hexon modified vectors were incubated with RPMI-...
<p>The anti-HIV-1 antibody production in mouse sera is shown at days 0 (T0), 14 (T1 and 28 (T2) from...
<p>Sera collected from immunized mice were diluted and used in ELISA assays to examine IgG1 and IgG2...
<p>BALB/c mice were immunized once with DNA encoding the indicated vaccine constructs. DNA (25 µg DN...
<p>Serum was collected from individual mouse immunized with DNA-B/MVA-B, DNA-B/MVA-B ΔC6L or DNA-B/M...
<p> Serum from individual immunized mice was analyzed using an HIV-1<sub>JR-CSF</sub> gp160 ELISA as...
<p>(A–B) Specific binding antibodies in immunized mouse sera to Bal gp120 (A) and HIV-1 06044 gp120 ...
<p>ELISA wells were coated with gp120<sub>MN</sub> or with MCPs listed in the Table, and antibody ti...
A) Schematic of the HIV Env or EboGP-pseudotyped HIV VLP immunization protocol used in this study. T...
In the present work we report our preliminary data demonstrating the susceptibility of mouse to HIV ...
In the present work we report our preliminary data demonstrating the susceptibility of mouse to HIV ...
<p><b>(A)</b> Serum of immunized mice from the memory phase were analyzed for total IgG response usi...
The immune parameters of HIV/AIDS vaccine candidates that might be relevant in protection against HI...
<p>Per antigen, eight mice were vaccinated twice with 5 µg antigen mixed with an oil-in-water adjuva...
<p>ELISA plates were coated with 2 μg/ml VLPs, gp120 Env, or Pr55 Gag. IgG1 quantitative ELISA of po...
<p>(A) 2x10<sup>10</sup> vp/mL of Ad5, Ad26 or Ad26 hexon modified vectors were incubated with RPMI-...
<p>The anti-HIV-1 antibody production in mouse sera is shown at days 0 (T0), 14 (T1 and 28 (T2) from...